Santen Pharmaceutical Co., Ltd.
General ticker "SNPHF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $3.9B (TTM average)
Santen Pharmaceutical Co., Ltd. follows the US Stock Market performance with the rate: 4.6%.
Estimated limits based on current volatility of 0.0%: low 9.51$, high 9.51$
Factors to consider:
- Company pays dividends (annually): last record date 2025-09-30, amount 0.13$ (Y1.37%)
Short-term SNPHF quotes
Long-term SNPHF plot
Financial data
| YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
|---|---|---|---|
| Operating Revenue | ¥266,257.00MM | ¥279,037.00MM | ¥301,965.00MM |
| Operating Expenses | ¥230,371.00MM | ¥282,127.00MM | ¥263,424.00MM |
| Operating Income | ¥35,886.00MM | ¥-3,090.00MM | ¥38,541.00MM |
| Non-Operating Income | ¥-270.00MM | ¥-2,709.00MM | ¥-8,667.00MM |
| Interest Expense | ¥1,209.00MM | ¥1,499.00MM | ¥2,664.00MM |
| R&D Expense | ¥26,377.00MM | ¥28,297.00MM | ¥25,416.00MM |
| Income(Loss) | ¥35,616.00MM | ¥-5,799.00MM | ¥29,874.00MM |
| Taxes | ¥8,427.00MM | ¥9,184.00MM | ¥3,171.00MM |
| Profit(Loss)* | ¥27,218.00MM | ¥-14,948.00MM | ¥26,642.00MM |
| Stockholders Equity | ¥337,488.00MM | ¥293,979.00MM | ¥306,055.00MM |
| Inventory | ¥37,141.00MM | ¥39,352.00MM | ¥43,185.00MM |
| Assets | ¥460,620.00MM | ¥421,861.00MM | ¥435,699.00MM |
| Operating Cash Flow | ¥46,043.00MM | ¥37,147.00MM | ¥72,649.00MM |
| Capital expenditure | ¥35,841.00MM | ¥24,588.00MM | ¥10,687.00MM |
| Investing Cash Flow | ¥-35,169.00MM | ¥-26,777.00MM | ¥-6,145.00MM |
| Financing Cash Flow | ¥5,557.00MM | ¥-37,220.00MM | ¥-34,031.00MM |
| Earnings Per Share** | ¥68.08 | ¥-38.58 | ¥72.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.